Inhaled hydrogen gas therapy for prevention of noise-induced hearing loss through reducing reactive oxygen species.
Takaomi Kurioka, Takeshi Matsunobu, Yasushi Satoh, Katsuki Niwa, Akihiro Shiotani · Neuroscience research · 2014
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In guinea pigs, strong immunoreactivities against 8-OHdG were observed of the non-treated group, the H₂-treated group showed decreased immunoreactivity for 8-OHdG. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how inhaled hydrogen gas affected the outcomes measured in guinea pigs. strong immunoreactivities against 8-OHdG were observed of the non-treated group, the H₂-treated group showed decreased immunoreactivity for 8-OHdG.
What the Researchers Studied
The researchers studied guinea pigs. The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
1.5% inhaled H₂ concentration. strong immunoreactivities against 8-OHdG were observed of the non-treated group, the H₂-treated group showed decreased immunoreactivity for 8-OHdG. The authors concluded that these findings strongly suggest that inhaled hydrogen gas protects against NIHL.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was guinea pigs. The study used a preclinical animal experiment. The hydrogen delivery method was inhaled hydrogen gas. The reported hydrogen concentration was 1.5% inhaled H₂ concentration.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.